Search research articles
Contact Us
Filters
Showing results (151-160 of 203) with videos related to
Page
of 21
Sort By:
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
JHEP Reports : Innovation in Hepatology
|
June 19, 2026
Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk
Constanze Hoebinger, Georg Semmler, Oleksandr Petrenko, et al.
Hepatology (Baltimore, Md.)
|
July 14, 2020
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Georg Semmler, Teresa Binter, Karin Kozbial, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
Cancers
|
December 11, 2022
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, et al.
Oncology Letters
|
August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab
Isaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
Najib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
Frontiers in Oncology
|
March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Y Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 203) with videos related to
Sort By:
Page
of 21
The American Journal of Gastroenterology
|
May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease
Monica Pons, Salvador Augustin, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics
|
April 14, 2019
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, et al.
Hepatology (Baltimore, Md.)
|
May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease
Lukas Hartl, Katharina Haslinger, Martin Angerer, et al.
JHEP Reports : Innovation in Hepatology
|
June 19, 2026
Alcohol intake reprograms hepatic immune-metabolic circuits to exacerbate murine atherosclerosis and human cardiovascular risk
Constanze Hoebinger, Georg Semmler, Oleksandr Petrenko, et al.
Hepatology (Baltimore, Md.)
|
July 14, 2020
Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
Georg Semmler, Teresa Binter, Karin Kozbial, et al.
Liver Cancer
|
August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
Cancers
|
December 11, 2022
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, et al.
Oncology Letters
|
August 27, 2025
Radiomics-based prediction of HCC response to atezolizumab/bevacizumab
Isaac Rodriguez, Abhinay Vellala, Timo Itzel, et al.
JHEP Reports : Innovation in Hepatology
|
May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
Najib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
Frontiers in Oncology
|
March 3, 2023
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Y Linda Wu, Grace van Hyfte, Umut Özbek, et al.
Page
of 21